^
    CANCER:

    Waldenstrom Macroglobulinemia





    Show legend
    Group by Gene:
    BTK inhibitor
    ibrutinib
    		0
    BTK inhibitor
    zanubrutinib
    acalabrutinib
    orelabrutinib
    1
    Proteasome inhibitor, CD20 inhibitor
    rituximab + ixazomib
    rituximab + bortezomib
    2
    CD20 inhibitor
    rituximab
    ofatumumab
    3
    Bcl2 inhibitor
    venetoclax
    4
    Purinergic receptor P1 agonist
    cladribine
    5
    DNA synthesis inhibitor
    fludarabine oral
    6
    mTOR inhibitor
    everolimus
    7
    Proteasome inhibitor
    bortezomib
    8
    DNA replication inhibitor
    bendamustine
    9
    CD38 inhibitor
    daratumumab
    10
    CXCR4 antagonist, BTK inhibitor
    ibrutinib + X4P-001
    ibrutinib + BMS-936564
    11
    CXCR4 antagonist
    X4P-001
    BDR
    RCP
    RCD
    		12
    Chemotherapy
    IRd
    R-CHOP
    BR
    CaRD
    FCR
    13
    BTK inhibitor, CD20 inhibitor
    ibrutinib + rituximab
    14
    Ionizing radiation emitter, DNA inhibitor
    CLR 131
    No biomarker
    CXCR4 mutation
    CXCR4 T318fs*
    CXCR4 S347fs*
    CXCR4 G336X
    CXCR4 S338X
    CXCR4 H350fs*
    CXCR4 R338X
    CXCR4 L326fs*
    CXCR4 K327fs*
    MYD88 L265P
    MYD88 wild-type
    MYD88 mutation
    MYD88 mutation + GPER1 expression
    MYD88 mutation + DUSP22 expression
    CD38 expression
    MYD88 mutation + CXCR4 mutation
    MYD88 mutation + PRDM15 expression
    MYD88 mutation + TNIK expression
    CXCR4 S338X + TP53 R196X
    MYD88 mutation + WNK2 expression
    MYD88 L265P + CXCR4 mutation